Journal of Gastric Cancer

  • 제18권3호
  • /
  • Pages.253-263
  • /
  • 2018
  • /
  • 2093-582X(pISSN)
  • /
  • 2093-5641(eISSN)
대한위암학회 (The Korean Gastric Cancer Association)
권호 표지
DOI QR코드

DOI QR Code

Impact of Various Types of Comorbidities on the Outcomes of Laparoscopic Total Gastrectomy in Patients with Gastric Carcinoma

  • Jeong, Oh (Division of Gastroenterologic Surgery, Department of Surgery, Chonnam National University Hwasun Hospital) ;
  • Jung, Mi Ran (Division of Gastroenterologic Surgery, Department of Surgery, Chonnam National University Hwasun Hospital) ;
  • Ryu, Seong Yeob (Division of Gastroenterologic Surgery, Department of Surgery, Chonnam National University Hwasun Hospital)
  • 투고 : 2018.06.27
  • 심사 : 2018.09.01
  • 발행 : 2018.09.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Purpose: With increasing life expectancy, the presence of comorbidities has become a major concern in elderly patients who require surgery. However, little is known about the impact of different comorbidities on the outcomes of laparoscopic total gastrectomy (LTG). In this study, we investigated the impact of comorbidities on postoperative complications in patients undergoing LTG for gastric carcinoma. Materials and Methods: We retrospectively reviewed the cases of 303 consecutive patients who underwent LTG for gastric carcinoma between 2005 and 2016. The associations between each comorbidity and postoperative complications were assessed using univariate and multivariate analyses. Results: A total of 189 patients (62.4%) had one or more comorbidities. Hypertension was the most common comorbidity (37.0%), followed by diabetes mellitus (17.8%), chronic viral hepatitis (2.6%), liver cirrhosis (2.6%), and pulmonary (27.1%), ischemic heart (3.3%), and cerebrovascular diseases (2.3%). The overall postoperative morbidity and mortality rates were 20.1% and 1.0%, respectively. Patients with pulmonary disease significantly showed higher complication rates than those without comorbidities (32.9% vs. 14.9%, respectively, P=0.003); patient with other comorbidities showed no significant difference in the incidence of LTG-related complications. During univariate and multivariate analyses, pulmonary disease was found to be an independent predictive factor for postoperative complications (odds ratio, 2.14; 95% confidence interval, 1.03-4.64), along with old age and intraoperative bleeding. Conclusions: Among the various comorbidities investigated, patients with pulmonary disease had a significantly higher risk of postoperative complications after LTG. Proper perioperative care for optimizing pulmonary function may be required for patients with pulmonary disease.

키워드

참고문헌

  1. Vinuela EF, Gonen M, Brennan MF, Coit DG, Strong VE. Laparoscopic versus open distal gastrectomy for gastric cancer: a meta-analysis of randomized controlled trials and high-quality nonrandomized studies. Ann Surg 2012;255:446-456. https://doi.org/10.1097/SLA.0b013e31824682f4
  2. Kim YW, Baik YH, Yun YH, Nam BH, Kim DH, Choi IJ, et al. Improved quality of life outcomes after laparoscopy-assisted distal gastrectomy for early gastric cancer: results of a prospective randomized clinical trial. Ann Surg 2008;248:721-727. https://doi.org/10.1097/SLA.0b013e318185e62e
  3. Information Committee of Korean Gastric Cancer Association. Korean Gastric Cancer Association nationwide survey on gastric cancer in 2014. J Gastric Cancer 2016;16:131-140. https://doi.org/10.5230/jgc.2016.16.3.131
  4. Etoh T, Shiraishi N, Kitano S. Current trends of laparoscopic gastrectomy for gastric cancer in Japan. Asian J Endosc Surg 2009;2:18-23. https://doi.org/10.1111/j.1758-5910.2009.00003.x
  5. Yu J, Hu J, Huang C, Ying M, Peng X, Wei H, et al. The impact of age and comorbidity on postoperative complications in patients with advanced gastric cancer after laparoscopic D2 gastrectomy: results from the Chinese laparoscropic gastrointestinal surgery study (CLASS) group. Eur J Surg Oncol 2013;39:1144-1149. https://doi.org/10.1016/j.ejso.2013.06.021
  6. Park JM, Jin SH, Lee SR, Kim H, Jung IH, Cho YK, et al. Complications with laparoscopically assisted gastrectomy: multivariate analysis of 300 consecutive cases. Surg Endosc 2008;22:2133-2139. https://doi.org/10.1007/s00464-008-9962-4
  7. Kim MC, Kim W, Kim HH, Ryu SW, Ryu SY, Song KY, et al. Risk factors associated with complication following laparoscopy-assisted gastrectomy for gastric cancer: a large-scale korean multicenter study. Ann Surg Oncol 2008;15:2692-2700. https://doi.org/10.1245/s10434-008-0075-z
  8. Inokuchi M, Otsuki S, Ogawa N, Tanioka T, Okuno K, Gokita K, et al. Postoperative complications of laparoscopic total Gastrectomy versus open total gastrectomy for gastric cancer in a meta-analysis of high-quality case-controlled studies. Gastroenterol Res Pract 2016;2016:2617903.
  9. Lin JX, Huang CM, Zheng CH, Li P, Xie JW, Wang JB, et al. Evaluation of laparoscopic total gastrectomy for advanced gastric cancer: results of a comparison with laparoscopic distal gastrectomy. Surg Endosc 2016;30:1988-1998. https://doi.org/10.1007/s00464-015-4429-x
  10. Jeong O, Ryu SY, Choi WY, Piao Z, Park YK. Risk factors and learning curve associated with postoperative morbidity of laparoscopic total gastrectomy for gastric carcinoma. Ann Surg Oncol 2014;21:2994-3001. https://doi.org/10.1245/s10434-014-3666-x
  11. Kawamura Y, Satoh S, Suda K, Ishida Y, Kanaya S, Uyama I. Critical factors that influence the early outcome of laparoscopic total gastrectomy. Gastric Cancer 2015;18:662-668. https://doi.org/10.1007/s10120-014-0392-9
  12. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 2011;14:101-112. https://doi.org/10.1007/s10120-011-0041-5
  13. Sobin LH, Gospodarowicz MK, Wittekind C. TNM Classification of Malignant Tumours. New York (NY): John Wiley & Sons, 2011.
  14. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-213. https://doi.org/10.1097/01.sla.0000133083.54934.ae
  15. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer 2017;20:1-19.
  16. Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev 2014;23:700-713. https://doi.org/10.1158/1055-9965.EPI-13-1057
  17. Tuder RM, Petrache I. Pathogenesis of chronic obstructive pulmonary disease. J Clin Invest 2012;122:2749-2755. https://doi.org/10.1172/JCI60324
  18. Fields AC, Divino CM. Surgical outcomes in patients with chronic obstructive pulmonary disease undergoing abdominal operations: An analysis of 331,425 patients. Surgery 2016;159:1210-1216. https://doi.org/10.1016/j.surg.2015.11.007
  19. Kim W, Song KY, Lee HJ, Han SU, Hyung WJ, Cho GS. The impact of comorbidity on surgical outcomes in laparoscopy-assisted distal gastrectomy: a retrospective analysis of multicenter results. Ann Surg 2008;248:793-799. https://doi.org/10.1097/SLA.0b013e3181887516
  20. Cho GS, Kim W, Kim HH, Ryu SW, Kim MC, Ryu SY. Multicentre study of the safety of laparoscopic subtotal gastrectomy for gastric cancer in the elderly. Br J Surg 2009;96:1437-1442. https://doi.org/10.1002/bjs.6777
  21. Wang JB, Zheng CH, Li P, Xie JW, Lin JX, Lu J, et al. Effect of comorbidities on postoperative complications in patients with gastric cancer after laparoscopy-assisted total gastrectomy: results from an 8-year experience at a large-scale single center. Surg Endosc 2017;31:2651-2660. https://doi.org/10.1007/s00464-016-5279-x
  22. Hwang SH, Park DJ, Jee YS, Kim HH, Lee HJ, Yang HK, et al. Risk factors for operative complications in elderly patients during laparoscopy-assisted gastrectomy. J Am Coll Surg 2009;208:186-192. https://doi.org/10.1016/j.jamcollsurg.2008.10.023
  23. Choi YS, Park DJ, Lee HJ, Kim HH, Yang HK, Lee KU. Laparoscopy-assisted distal gastrectomy for gastric cancer patients with comorbid diseases: is it contraindicated for patients with systemic comorbidity? Surg Laparosc Endosc Percutan Tech 2011;21:33-36. https://doi.org/10.1097/SLE.0b013e3182050c47
  24. Inokuchi M, Kato K, Sugita H, Otsuki S, Kojima K. Impact of comorbidities on postoperative complications in patients undergoing laparoscopy-assisted gastrectomy for gastric cancer. BMC Surg 2014;14:97. https://doi.org/10.1186/1471-2482-14-97
  25. Smetana GW, Lawrence VA, Cornell JE; American College of Physicians. Preoperative pulmonary risk stratification for noncardiothoracic surgery: systematic review for the American College of Physicians. Ann Intern Med 2006;144:581-595. https://doi.org/10.7326/0003-4819-144-8-200604180-00009
  26. Jeong O, Ryu SY, Park YK. The value of preoperative lung spirometry test for predicting the operative risk in patients undergoing gastric cancer surgery. J Korean Surg Soc 2013;84:18-26. https://doi.org/10.4174/jkss.2013.84.1.18
  27. Barisione G, Rovida S, Gazzaniga GM, Fontana L. Upper abdominal surgery: does a lung function test exist to predict early severe postoperative respiratory complications? Eur Respir J 1997;10:1301-1308. https://doi.org/10.1183/09031936.97.10061301
  28. Jacober SJ, Sowers JR. An update on perioperative management of diabetes. Arch Intern Med 1999;159:2405-2411. https://doi.org/10.1001/archinte.159.20.2405
  29. Varon J, Marik PE. Perioperative hypertension management. Vasc Health Risk Manag 2008;4:615-627. https://doi.org/10.2147/VHRM.S2471
  30. Niederman MS, Clemente PH, Fein AM, Feinsilver SH, Robinson DA, Ilowite JS, et al. Benefits of a multidisciplinary pulmonary rehabilitation program. Improvements are independent of lung function. Chest 1991;99:798-804. https://doi.org/10.1378/chest.99.4.798
  31. Pasquina P, Tramer MR, Granier JM, Walder B. Respiratory physiotherapy to prevent pulmonary complications after abdominal surgery: a systematic review. Chest 2006;130:1887-1899. https://doi.org/10.1378/chest.130.6.1887
  32. Gracey DR, Divertie MB, Didier EP. Preoperative pulmonary preparation of patients with chronic obstructive pulmonary disease: a prospective study. Chest 1979;76:123-129. https://doi.org/10.1378/chest.76.2.123
  33. Huang KW, Kuan YC, Chi NF, Huang YH, Luo JC, Chien LN. Chronic obstructive pulmonary disease is associated with increased recurrent peptic ulcer bleeding risk. Eur J Intern Med 2017;37:75-82. https://doi.org/10.1016/j.ejim.2016.09.020
  34. Christensen S, Thomsen RW, Torring ML, Riis A, Norgaard M, Sorensen HT. Impact of COPD on outcome among patients with complicated peptic ulcer. Chest 2008;133:1360-1366. https://doi.org/10.1378/chest.07-2543
  35. MacNee W. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005;2:50-60. https://doi.org/10.1513/pats.200411-056SF
  36. Luo JC, Lin HY, Lu CL, Wang LY, Chang FY, Lin HC, et al. Dexamethasone inhibits basic fibroblast growth factor-stimulated gastric epithelial cell proliferation. Biochem Pharmacol 2008;76:841-849. https://doi.org/10.1016/j.bcp.2008.07.010

피인용 문헌

  1. Real-life use of ramucirumab in gastric cancer in Spain: the RAMIS study vol.17, pp.14, 2018, https://doi.org/10.2217/fon-2020-1216